Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users

OBJECTIVES: To investigate the impact of harm-reduction programmes on HIV and hepatitis C virus (HCV) incidence among ever-injecting drug users (DU) from the Amsterdam Cohort Studies (ACS). METHODS: The association between use of harm reduction and seroconversion for human immunodeficiency virus (HI...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Den Berg, Charlotte, Smit, Colette, Van Brussel, Giel, Coutinho, Roel, Prins, Maria
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2007
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040242/
https://www.ncbi.nlm.nih.gov/pubmed/17697278
http://dx.doi.org/10.1111/j.1360-0443.2007.01912.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040242/
https://www.ncbi.nlm.nih.gov/pubmed/17697278
http://dx.doi.org/10.1111/j.1360-0443.2007.01912.x

Ejemplares similares